For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Genius Sports Limited (NYSE: GENI) closed the day trading at $12.91 down -0.15% from the previous closing price of $12.93. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 4.45 million shares were traded. GENI stock price reached its highest trading level at $12.98 during the session, while it also had its lowest trading level at $12.57.
Ratios:
For a better understanding of GENI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 87.23. For the most recent quarter (mrq), Quick Ratio is recorded 2.35 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on July 25, 2025, initiated with a Outperform rating and assigned the stock a target price of $14.
On July 09, 2025, Arete started tracking the stock assigning a Buy rating and target price of $15.
On July 01, 2025, Truist started tracking the stock assigning a Buy rating and target price of $14.Truist initiated its Buy rating on July 01, 2025, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 13 ’25 when Burns Daniel Paul bought 8,157 shares for $10.45 per share.
Stevens Eric bought 79,373 shares of GENI for $744,519 on Mar 06 ’25. On Jan 17 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 100,388 shares for $8.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 3078273280 and an Enterprise Value of 2868257280. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.88 while its Price-to-Book (P/B) ratio in mrq is 4.27. Its current Enterprise Value per Revenue stands at 5.136 whereas that against EBITDA is -31.532.
Stock Price History:
The Beta on a monthly basis for GENI is 1.88, which has changed by 0.7709191 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $12.94, while it has fallen to a 52-week low of $6.72. The 50-Day Moving Average of the stock is 21.18%, while the 200-Day Moving Average is calculated to be 33.61%.
Shares Statistics:
Over the past 3-months, GENI traded about 5.48M shares per day on average, while over the past 10 days, GENI traded about 7467870 shares per day. A total of 238.44M shares are outstanding, with a floating share count of 215.34M. Insiders hold about 10.20% of the company’s shares, while institutions hold 100.24% stake in the company. Shares short for GENI as of 1753920000 were 28618482 with a Short Ratio of 5.23, compared to 1751241600 on 24920009. Therefore, it implies a Short% of Shares Outstanding of 28618482 and a Short% of Float of 13.13.
Earnings Estimates
Current recommendations for the stock of the company come from 1.0 analysts. The consensus estimate for the next quarter is $0.12, with high estimates of $0.12 and low estimates of $0.12.
Analysts are recommending an EPS of between $0.3 and $0.3 for the fiscal current year, implying an average EPS of $0.3. EPS for the following year is $0.41, with 1.0 analysts recommending between $0.41 and $0.41.
Revenue Estimates
15 analysts predict $157.51M in revenue for the current quarter. It ranges from a high estimate of $159.1M to a low estimate of $154.5M. As of the current estimate, Genius Sports Limited’s year-ago sales were $120.2MFor the next quarter, 15 analysts are estimating revenue of $224.84M. There is a high estimate of $229M for the next quarter, whereas the lowest estimate is $222.9M.
A total of 15 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $649.5M, while the lowest revenue estimate was $641.4M, resulting in an average revenue estimate of $645.07M. In the same quarter a year ago, actual revenue was $510.89MBased on 16 analysts’ estimates, the company’s revenue will be $752.37M in the next fiscal year. The high estimate is $772.6M and the low estimate is $709.01M.
